N
Neuros Medical
Developing proprietary neurostimulation therapies for unmet needs to patients worldwide
About Neuros Medical
Neuros Medical, Inc., based in Cleveland, Ohio, is a neuromodulation company specializing in the development of proprietary therapies aimed at addressing unmet medical needs related to chronic pain. The company's patented platform technology, Electrical Nerve Block, focuses on treating various forms of chronic pain, including post-amputation pain, chronic post-surgical pain, and chronic migraines.
Neuros Medical primarily serves patients suffering from long-term pain conditions, which are often inadequately managed by existing treatments. The company operates within the medical technology market, specifically targeting the pain management segment.
Neuros Medical's business model revolves around the development and clinical testing of its proprietary Electrical Nerve Block technology. The company generates revenue through partnerships, licensing agreements, and potentially future sales of its medical devices once they receive regulatory approval.
The company's innovative approach aims to provide effective pain relief solutions, thereby improving the quality of life for patients worldwide.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Willoughby, United States
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 90.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Rehabilitation, Biotechnology, Surgery, Neurology, Spinout, Biotech and Pharma, DT and LS
- Technology
- Big Data, Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Mar 2026 | $35M | — | Trinity Capital | ↗ |
| SERIES DOther financing | Jul 2025 | $56M | $224M | U.S. Venture Partners · Osage University Partners · Aperture Venture Partners · Amzak Health | ↗ |
Growth signals
Latest recorded traffic for Neuros Medical is 2.4K monthly website visits, up 20% over the last three months. Neuros Medical's team declined 1.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A10 investors entered at this stage
U.S. Venture Partners
Boston Scientific
Aperture Ventures Partners
RiverVest Venture Partners
Osage University Partners
Sectoral Asset Management
Amzak Capital Management
InCube Ventures- APAperture Venture Partners
- AIAmzak Health Investors
Series B and later3 investors entered at this stage
Trinity Capital
EQT Life Sciences
Amzak Health
Other known investors1 additional known investor
Case Western Reserve University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neuros Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neuros Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.